Fed. Circ. Won't Let Jazz Keep System Patent In Orange Book
Jazz Pharmaceuticals must remove a patent from the Orange Book listing for its blockbuster narcolepsy drug Xyrem, as it covers neither the drug itself nor a method of using it, the...To view the full article, register now.
Already a subscriber? Click here to view full article